(Q28320643)

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

24 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A179295

23 May 2022

author name string

P. E. Schurr

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A179295

23 May 2022

J. R. Schultz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A179295

23 May 2022

C. E. Day

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A179295

full work available at URL

23 May 2022

language of work or name

English

0 references

publication date

1976

0 references

http://link.springer.com/content/pdf/10.1007/978-1-4614-4618-7_13

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

Advances in Experimental Medicine and Biology

23 May 2022

published in

0 references

volume

67

0 references

issue

00

0 references

page(s)

215-229

0 references

cites work

Comparative biochemistry and physiology

3

46B

295

C Alexander

1973

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

Comparative biochemistry and physiology

23 May 2022

4

49B

501

CE Day

1974

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

Biological Activity of a Hypobetalipoproteinemic Agent

23 May 2022

5

231

CE Day

1976

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

Specific inhibition of cholesterol biosynthesis by a synthetic compound (MER-29)

23 May 2022

11

85

245

TR Blohm

1959

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

AN EXPERIMENTAL APPROACH TO THE PROBLEM OF DISORDERED LIPID METABOLISM

23 May 2022

12

3

351

JM Thorp

1963

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)— A new hypolipidemic agent

23 May 2022

13

18

1861

AR Timms

1969

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

Treatment of hyperlipidemia

23 May 2022

14

290

1295

RI Levy

1974

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

The hypocholesterolemic action of eritadenine in the rat

23 May 2022

15

17

491

K Takashima

1973

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

ESTRONE INHIBITION OF CHOLESTEROL BIOSYNTHESIS AT THE MEVALONIC ACID STAGE

23 May 2022

17

144

301

AJ Merola

1964

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

Long-term effects of high-dosage estrogen therapy in men with coronary heart disease

23 May 2022

18

16

155

RW Robinson

1963

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

Hypo-.beta.-lipoproteinemic agents. 1. Bicyclo[2.2.2]octyloxyaniline and its derivatives

23 May 2022

19

18

1065

CE Day

1975

1 reference

https://api.crossref.org/works/10.1007/978-1-4614-4618-7_13

23 May 2022

Identifiers

1 reference

National Center for Biotechnology Information